Laparoscopic Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Metastatic Gastric Cancer
Status:
Completed
Trial end date:
2020-05-12
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if hyperthermic intraperitoneal
chemotherapy (HIPEC) will help to control the disease in patients with Stage 4 stomach or
gastroesophageal cancer. The safety of this treatment will also be studied.